Currently, studies have shown that one in three people infected with coronavirus disease-19 (COVID-19) is likely
to have had long-term exposure to COVID-19, known as long-term COVID-19. Clinical studies indicate that many
people infected with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) COVID-19 pandemic have
long-term COVID-19 exposure. According to the study, it has been said that people with diabetes and obesity, and
people who have received organ transplants, are more likely to suffer from this long-term effect of COVID-19. In
this article, the effects of long-term COVID-19 exposure on neurological disability patients are analyzed with the
help of a neuromachine learning model.
The document discusses facts and opinions about the COVID-19 pandemic. It provides details about the virus such as it being derived from bats, how it spreads mainly through droplets from coughs or sneezes, and its global impact with over 7 million confirmed cases. The document also discusses the virus's symptoms and how they develop over time, from initial fever to potential respiratory distress. It emphasizes the importance of following government health protocols to prevent transmission and protect lives.
The document provides information on the COVID-19 pandemic as of April 2020. It discusses the epidemiology and spread of the virus globally. Key points include:
- COVID-19 originated in Wuhan, China in late 2019 and has since spread to over 210 countries. As of April 2020, there were over 29 lakh confirmed cases and 200,568 deaths worldwide, with the US becoming the new epicenter.
- The virus spreads mainly person-to-person via respiratory droplets. Common symptoms include fever, cough and shortness of breath, though many cases are asymptomatic. Chest CT scans show bilateral lung involvement like ground-glass opacities or consolidation.
- While most cases are mild, the elderly and those
The document provides information on the novel coronavirus (COVID-19) pandemic, including:
1) It describes the epidemiology and spread of COVID-19 globally, with over 29 lakh reported cases across 210 countries as of April 2020, and identifies the United States as the new epicenter.
2) It summarizes the natural history and clinical presentation of COVID-19, which commonly includes fever, cough, and shortness of breath, and can progress to severe pneumonia and multi-organ failure in vulnerable groups.
3) It discusses diagnosis of COVID-19 using RT-PCR testing of respiratory samples and treatment being primarily supportive care and ventilation for severe cases, as there is no proven antiviral treatment yet.
This document provides information on COVID-19 in Indonesia, including facts and opinions. It discusses the origin and spread of the virus, symptoms, prevention methods, government response policies, myths and WHO guidance. Data on patient demographics and the latest case numbers in Indonesia are also presented. The document synthesizes information from various academic and news sources on the COVID-19 outbreak in the country.
This document summarizes the current understanding of long-term sequelae, or post-COVID conditions, among children and adolescents. It finds that post-COVID conditions can occur in children and adolescents regardless of the severity of their initial COVID-19 infection. Symptoms are wide-ranging and can include fatigue, respiratory difficulties, brain fog, and mood changes. While most studies have limitations, prevalence estimates suggest 5-30% of children may experience post-COVID conditions. Risk may be higher in adolescents, those hospitalized for COVID-19, and those with multisystem inflammatory syndrome. Many questions remain about associated factors, duration, and impact on daily life. Vaccination against COVID-19 may help reduce risks of long-term
The 2019–20 coronavirus pandemic is an ongoing pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).[4] The outbreak was first identified in Wuhan, Hubei, China, in December 2019, and was recognized as a pandemic by the World Health Organization (WHO) on 11 March 2020.[5] As of 25 March, more than 422,000 cases of COVID-19 have been reported in more than 190 countries and territories, resulting in more than 18,900 deaths and more than 109,000 recoveries.
The document discusses facts and opinions about the COVID-19 pandemic. It provides details about the virus such as it being derived from bats, how it spreads mainly through droplets from coughs or sneezes, and its global impact with over 7 million confirmed cases. The document also discusses the virus's symptoms and how they develop over time, from initial fever to potential respiratory distress. It emphasizes the importance of following government health protocols to prevent transmission and protect lives.
The document provides information on the COVID-19 pandemic as of April 2020. It discusses the epidemiology and spread of the virus globally. Key points include:
- COVID-19 originated in Wuhan, China in late 2019 and has since spread to over 210 countries. As of April 2020, there were over 29 lakh confirmed cases and 200,568 deaths worldwide, with the US becoming the new epicenter.
- The virus spreads mainly person-to-person via respiratory droplets. Common symptoms include fever, cough and shortness of breath, though many cases are asymptomatic. Chest CT scans show bilateral lung involvement like ground-glass opacities or consolidation.
- While most cases are mild, the elderly and those
The document provides information on the novel coronavirus (COVID-19) pandemic, including:
1) It describes the epidemiology and spread of COVID-19 globally, with over 29 lakh reported cases across 210 countries as of April 2020, and identifies the United States as the new epicenter.
2) It summarizes the natural history and clinical presentation of COVID-19, which commonly includes fever, cough, and shortness of breath, and can progress to severe pneumonia and multi-organ failure in vulnerable groups.
3) It discusses diagnosis of COVID-19 using RT-PCR testing of respiratory samples and treatment being primarily supportive care and ventilation for severe cases, as there is no proven antiviral treatment yet.
This document provides information on COVID-19 in Indonesia, including facts and opinions. It discusses the origin and spread of the virus, symptoms, prevention methods, government response policies, myths and WHO guidance. Data on patient demographics and the latest case numbers in Indonesia are also presented. The document synthesizes information from various academic and news sources on the COVID-19 outbreak in the country.
This document summarizes the current understanding of long-term sequelae, or post-COVID conditions, among children and adolescents. It finds that post-COVID conditions can occur in children and adolescents regardless of the severity of their initial COVID-19 infection. Symptoms are wide-ranging and can include fatigue, respiratory difficulties, brain fog, and mood changes. While most studies have limitations, prevalence estimates suggest 5-30% of children may experience post-COVID conditions. Risk may be higher in adolescents, those hospitalized for COVID-19, and those with multisystem inflammatory syndrome. Many questions remain about associated factors, duration, and impact on daily life. Vaccination against COVID-19 may help reduce risks of long-term
The 2019–20 coronavirus pandemic is an ongoing pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).[4] The outbreak was first identified in Wuhan, Hubei, China, in December 2019, and was recognized as a pandemic by the World Health Organization (WHO) on 11 March 2020.[5] As of 25 March, more than 422,000 cases of COVID-19 have been reported in more than 190 countries and territories, resulting in more than 18,900 deaths and more than 109,000 recoveries.
This document describes the clinical presentation of a 54-year-old male patient admitted to the hospital with COVID-19. It provides details of the patient's medical history, symptoms, physical examination findings, lab and imaging results, medications and treatment plan. It also discusses coronavirus in general, including the classification of different types, origin, transmission, incubation period, clinical manifestations and diagnostic evaluation, management and prevention of COVID-19.
This study investigated the clinical features of headaches in 102 patients with long COVID. It found that patients with pre-existing headaches experienced longer headaches during long COVID compared to before infection. Those with headaches had higher disability levels and were more likely to develop chronic headaches. Factors associated with headaches in long COVID included hospitalization, back pain, insomnia, and numbness. The study aims to better understand the characteristics and risk factors of headaches for patients experiencing long COVID.
1) The document discusses the coronavirus (COVID-19) pandemic, providing details on the history and characteristics of coronaviruses, symptoms of COVID-19, definitions used in classifying cases, and accuracy of global data on the spread and mortality risk of the virus.
2) It notes that while coronaviruses have infected humans for years, the current strain spreading worldwide is a version that replicates well at human body temperature.
3) Key terms discussed include incubation period, close contact, suspect/probable/confirmed cases, and stages of COVID-19 illness and recovery times. Global data shows cases are doubling every 3-27 days in different locations.
This document summarizes evidence on neuropsychiatric manifestations in COVID-19 survivors ("long COVID"). It finds that depression, anxiety, PTSD, sleep disturbances, fatigue and cognitive deficits are commonly reported neuropsychiatric symptoms. Studies show that months after initial infection, a significant proportion of survivors experience these symptoms. The severity of the initial COVID-19 infection and inflammation are associated with increased risk and severity of neuropsychiatric symptoms over time. However, the pathophysiological mechanisms underlying neuropsychiatric manifestations in long COVID remain incompletely understood.
To Assess the Severity and Mortality among Covid 19 Patients after Having Vac...YogeshIJTSRD
The severity and mortality of COVID 19 cases has been associated with the Three category such as vaccination status, severity of disease and outcome. Objective presently study was aimed to assess the severity and mortality among covid 19 patients. Methods Using simple lottery random method 100 samples were selected. From these 100 patients, 50 patients were randomly assigned to case group and 50 patients in control group after informed consents of relative obtained. Patients in the case group who being died after got COVID 19 whereas 50 patients in the control group participated who were survive after got infected from COVID 19 patients. Result It has three categories such as a Vaccination status For the vaccination status we have seen 59 patients were not vaccinated and 41 patients was vaccinated out of 100. b Incidence There were 41 patients were vaccinated whereas 59 patients were not vaccinated. c Severity In the case of mortality we selected 50 patients who were died from the Corona and I got to know that out of 50 patients there were 12 24 patients were vaccinated whereas 38 76 patients were non vaccinated. Although for the 50 control survival group total 29 58 patients were vaccinated and 21 42 patients was not vaccinated all graph start. Conclusion we have find out that those people who got vaccinated were less infected and mortality rate very low. Prof. (Dr) Binod Kumar Singh | Dr. Saroj Kumar | Ms. Anuradha Sharma "To Assess the Severity and Mortality among Covid-19 Patients after Having Vaccinated: A Retrospective Study" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-5 , August 2021, URL: https://www.ijtsrd.com/papers/ijtsrd45065.pdf Paper URL: https://www.ijtsrd.com/other-scientific-research-area/other/45065/to-assess-the-severity-and-mortality-among-covid19-patients-after-having-vaccinated-a-retrospective-study/prof-dr-binod-kumar-singh
Archisman Nandy
The objective of this study is to make a comparison between five (5) most affected countries (USA, Brazil, U.K., Italy and India) of the world by Covid-19. The study is based on the secondary data. For conducting this study published data in online portal www.worldometers.info has been used. 4 months i.e. August 2020 to November 2020 has been chosen to carry out this study. For data analysis and interpretation Microsoft excel software (version 2019) has been used. Basic arithmetic technique and ratio analysis has been used in this study for data interpretation purpose. For measuring cyclical fluctuations in Covid-19 cases and its corresponding death cases, visual representation has been incorporated as bar diagram. Relevant images have been sourced from authentic sources and used in this study for satisfying the research objective. Finally the study has revealed that during the period of August 2020 to November 2020 Brazil is the most affected country and United States of America is the least affected country based on the mortality rate among the five countries taken as sample for this study
Evaluation of Signs and Symptoms Post Recovery in COVID Patients: A Questionn...DrHeena tiwari
This document describes a questionnaire survey of 287 individuals who recovered from COVID-19. The survey found that only 10.8% reported no ongoing symptoms, while most reported fatigue (72.8%), anxiety (38%), joint pain (31.4%), or other symptoms. Symptom severity was related to severity of initial COVID-19 infection and presence of pre-existing conditions. The study aims to evaluate ongoing signs and symptoms in post-recovery COVID patients.
This document discusses long-term or post-COVID conditions that can occur in people who have had COVID-19. It defines post-COVID conditions as new, returning, or ongoing health problems that can last 4 or more weeks after initial infection. Common symptoms include fatigue, shortness of breath, brain fog, and joint pain. Post-COVID conditions can result from direct organ damage from severe COVID-19, as well as indirect effects like those from extended hospitalization. Both children and adults can experience post-COVID conditions. The best prevention is vaccination against COVID-19.
This document reviews the neurological sequelae of COVID-19. It finds that COVID-19 can cause olfactory and respiratory dysfunction with average recovery within 1 month, though some patients experience symptoms up to 8 months later. Headaches are also very common in patients with persistent COVID-19 symptoms. The document concludes that while many studies have focused on acute COVID-19 symptoms, more longitudinal studies are needed to fully assess neurological sequelae.
Affects of SARS Cov 2 on Different Parts HHW.pptxRakeshKhetrapal1
The document discusses how SARS CoV 2 affects different parts of the human body. It outlines that the virus can cause lung complications like pneumonia and ARDS. It also affects the kidneys by potentially causing harm and loss of function. The brain is affected as well, with patients experiencing issues ranging from loss of smell and taste to life-threatening strokes. The liver can also be impacted, with people with preexisting liver conditions at higher risk of severe illness. While the evidence of ocular transmission is still being studied, the eyes' mucus membranes make them susceptible to infection if droplets enter the eye.
Affects of SARS Cov 2 on Different Parts HHW.pptxRakeshKhetrapal1
The document discusses how SARS CoV 2 affects different parts of the human body. It outlines that the virus can cause lung complications like pneumonia and ARDS. It also affects the kidneys by potentially causing harm and loss of function. The brain is affected as well, with patients experiencing issues ranging from loss of smell and taste to life-threatening strokes. The liver can also be impacted, with people with preexisting liver conditions at higher risk of severe illness. While the evidence of ocular transmission is still being studied, the eyes' mucus membranes make them susceptible to infection if droplets enter the eye.
Long COVID_ Only THESE 7 Symptoms Are The Direct Result.pdfmyhealthfitclub
Long COVID - myhealthfitclub
Long COVID: Only THESE 7 Symptoms Are The Direct Result
02/02/2023 by Yogesh
Long COVID : Post-COVID Condition
Long Covid : If you have recovered from COVID-19 but are still experiencing certain symptoms you could have post Corona Virus condition or “long Corona virus”. What are these symptoms? How long do they last and are there any treatment options?
Also Read : Most Effective Abs Exercises To Burn Belly Fat
01/9 Symptoms Of Long COVID To Look For
01/9 Symptoms of long COVID to look for
Long COVID or post-corona virus condition has been associated with a long list of symptoms. However, a new study has found that there are only 7 long-term health symptoms that are directly associated with long corona virus. These symptoms can interfere with your day-to-day functioning and you may not be able to function exactly like before your initial COVID_infection. The findings can help researchers better understand how SARS-CoV-2 may mutate.
Also Read : Know What Is Parkinson’s Disease And Symptoms ?
02/9 About the study
The researchers at the University of Missouri analyzed 52,461 patients’ electronic medical records in the United States. All of the patients had been diagnosed with a Corona virus infection before April 14, 2022.Researchers studied the top 47 most commonly reported health symptoms from long-COVID. They found only seven of the symptoms applied to a subgroup of infected adult patients. Following are the 7 symptoms, which can last up to a year.
03/9 Fast-beating heart
This symptom includes feeling your heart beat rapidly or irregularly in your chest. You may also feel lightheaded or dizzy, especially upon standing.
Read more: Know What Is Pneumonia How To Identify ?
04/9 Long COVID – Hair loss
04/9 Long COVID - Hair loss
People can experience hair fall long after COVID, due to a condition called Telogen Effluvium. This can happen when your body is subjected to physical and emotional stress, such as while fighting a COVID_infection. The stress from COVID_shocks your body and disrupts the growth-rest cycle. This results in an increased shedding of hair.
05/9 Long COVID – Fatigue
05/9 Long COVID - Fatigue
This is one of the most common long COVID symptoms. Researchers in Iran undertook a meta-analysis covering 52 studies with 127,117 participants. They found that 42.5% of people who develop long_COVID have chronic fatigue that can persist for months, despite medical care.
Read more: Do BB.1.5 Variant Of Omicron Infect People : WHO?
06/9 Long COVID – Chest pain
06/9 Long COVID - Chest pain
Chest pain or chest discomfort is also a common symptom of long COVID. This type of pain can feel like the muscles in your chest are sore. It can hurt when you touch it and the pain gets worse from movements such as turning around or stretching.
07/9 Shortness of breath
Long after your initial COVID infection, you may find yourself catching your breath and feel short of breath more easily. This can happen even if you d
COVID-19 AND UROLOGY: A Comprehensive Review of the LiteratureValentina Corona
This article reviews the impact of the COVID-19 pandemic on the practice of urology. It discusses how the pandemic has led to the postponement of non-urgent surgeries and changes in residency training. It also examines the potential effects of COVID-19 on the urinary tract, noting that the kidneys and bladder may be at risk of viral invasion due to the presence of ACE2 receptors. The article reviews recommendations regarding kidney transplantation during the pandemic and reports limited cases of COVID-19 infection in renal transplant recipients.
The document discusses coronavirus disease (COVID-19) including its definition, transmission, clinical presentation, course, and diagnostic testing recommendations. It defines healthcare personnel and notes COVID-19 is a new coronavirus strain discovered in 2019 that is zoonotic, mainly spread through respiratory droplets. Symptoms can range from mild to severe and include fever, cough and shortness of breath. Older patients and those with chronic conditions are at higher risk. Diagnostic testing is recommended for suspected cases using molecular tests on respiratory specimens.
COVID-19: советы ВОЗ по использованию масокPravotv
This document provides updated guidance from the WHO on the use of medical and non-medical masks in the context of the COVID-19 pandemic. It summarizes evidence that COVID-19 spreads via respiratory droplets and contact with infected surfaces. The guidance recommends medical masks for health workers providing direct care to COVID-19 patients without aerosol-generating procedures, and respirators for those performing such procedures. It also recommends targeted continuous use of medical masks by health workers in areas with community COVID-19 transmission.
The document provides information on COVID-19 and ways to protect against it. It discusses what coronaviruses are, details of the SARS-CoV-2 virus, how the disease spreads via respiratory droplets, those most at risk like the elderly and those with pre-existing conditions, common symptoms like fever and cough, and the importance of practices like hand washing, social distancing, and masks to prevent transmission. It aims to fight misinformation by providing an authentic resource on understanding the pandemic and staying safe.
This document provides an overview of COVID-19, including its epidemiology, risk factors, pathophysiology, symptoms, transmission, diagnosis, treatment, prevention, and nursing interventions. It notes that over 3.3 million new cases were reported globally in the past week, with nearly 46 million total cases and 1.2 million deaths. Common symptoms include fever, cough, and fatigue, while severe symptoms can include trouble breathing, organ failure, and death. The main modes of transmission are respiratory droplets and contact with contaminated surfaces. Treatment focuses on managing symptoms, as there is no vaccine or antiviral specifically for COVID-19. Prevention emphasizes hand hygiene, physical distancing, and use of face coverings.
Guillain Barre Syndrome & Covid-19: A Case Reportclinicsoncology
Besides respiratory symptoms, coronavirus disease 2019 (COVID-19), like the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), has neurological signs. Symptoms like myalgia, headaches, dizziness, anosmia, ageusia and disorder of consciousness confirms that the nervous system is involved in COVID-19 infection.
Guillain Barre Syndrome & Covid-19: A Case Reportpateldrona
Besides respiratory symptoms, coronavirus disease 2019 (COVID-19), like the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), has neurological signs
Guillain Barre Syndrome & Covid-19: A Case Reportkomalicarol
Besides respiratory symptoms, coronavirus disease 2019
(COVID-19), like the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), has neurological signs. Symptoms like myalgia,
headaches, dizziness, anosmia, ageusia and disorder of consciousness confirms that the nervous system is involved in COVID-19 infection. Guillain barre syndrome (GBS) is a neurological disorder
that usually follows a viral infection, it is possible that COVID-19
infection and GBS are closely related. In this case report, we try to
elucidate the relation between SARS-CoV-2 and GBS.
A case report of posterior reversible encephalopathy syndrome in a patient di...bijnnjournal
Posterior reversible encephalopathy syndrome (PRES), a clinical radiological syndrome, is characterized by the
abrupt development of neurological symptoms such as headaches, convulsions, altered sensorium, and visual
problems. PRES has been linked to a number of risk factors or etiologies, including the use of immunosuppressants
or cytotoxins, hypertensive encephalopathy, eclampsia, preeclampsia, and underlying autoimmune diseases.
A 41-year-old female was admitted with acute necrotizing emphysematous pancreatitis complicated by posterior
reversible encephalopathy syndrome
Balint syndrome: an unusual triad, Balint syndrome: an unusual triadbijnnjournal
The paper investigates a case of sudden loss of vision in a patient with recent history of blurred vision of right eye
diagnosed with Central retinal artery occlusion (CRAO). The point of interest of this case report is that the clinical
features are something different from those of a CRAO and revealed cardinal triad of simultanagnosia, optic ataxia,
and oculomotor apraxia which are conclusive of a rare clinical entity known as Balint syndrome.
More Related Content
Similar to Examination of the effects of long-term COVID-19 impacts on patients with neurological disabilities using a neuromachine learning model
This document describes the clinical presentation of a 54-year-old male patient admitted to the hospital with COVID-19. It provides details of the patient's medical history, symptoms, physical examination findings, lab and imaging results, medications and treatment plan. It also discusses coronavirus in general, including the classification of different types, origin, transmission, incubation period, clinical manifestations and diagnostic evaluation, management and prevention of COVID-19.
This study investigated the clinical features of headaches in 102 patients with long COVID. It found that patients with pre-existing headaches experienced longer headaches during long COVID compared to before infection. Those with headaches had higher disability levels and were more likely to develop chronic headaches. Factors associated with headaches in long COVID included hospitalization, back pain, insomnia, and numbness. The study aims to better understand the characteristics and risk factors of headaches for patients experiencing long COVID.
1) The document discusses the coronavirus (COVID-19) pandemic, providing details on the history and characteristics of coronaviruses, symptoms of COVID-19, definitions used in classifying cases, and accuracy of global data on the spread and mortality risk of the virus.
2) It notes that while coronaviruses have infected humans for years, the current strain spreading worldwide is a version that replicates well at human body temperature.
3) Key terms discussed include incubation period, close contact, suspect/probable/confirmed cases, and stages of COVID-19 illness and recovery times. Global data shows cases are doubling every 3-27 days in different locations.
This document summarizes evidence on neuropsychiatric manifestations in COVID-19 survivors ("long COVID"). It finds that depression, anxiety, PTSD, sleep disturbances, fatigue and cognitive deficits are commonly reported neuropsychiatric symptoms. Studies show that months after initial infection, a significant proportion of survivors experience these symptoms. The severity of the initial COVID-19 infection and inflammation are associated with increased risk and severity of neuropsychiatric symptoms over time. However, the pathophysiological mechanisms underlying neuropsychiatric manifestations in long COVID remain incompletely understood.
To Assess the Severity and Mortality among Covid 19 Patients after Having Vac...YogeshIJTSRD
The severity and mortality of COVID 19 cases has been associated with the Three category such as vaccination status, severity of disease and outcome. Objective presently study was aimed to assess the severity and mortality among covid 19 patients. Methods Using simple lottery random method 100 samples were selected. From these 100 patients, 50 patients were randomly assigned to case group and 50 patients in control group after informed consents of relative obtained. Patients in the case group who being died after got COVID 19 whereas 50 patients in the control group participated who were survive after got infected from COVID 19 patients. Result It has three categories such as a Vaccination status For the vaccination status we have seen 59 patients were not vaccinated and 41 patients was vaccinated out of 100. b Incidence There were 41 patients were vaccinated whereas 59 patients were not vaccinated. c Severity In the case of mortality we selected 50 patients who were died from the Corona and I got to know that out of 50 patients there were 12 24 patients were vaccinated whereas 38 76 patients were non vaccinated. Although for the 50 control survival group total 29 58 patients were vaccinated and 21 42 patients was not vaccinated all graph start. Conclusion we have find out that those people who got vaccinated were less infected and mortality rate very low. Prof. (Dr) Binod Kumar Singh | Dr. Saroj Kumar | Ms. Anuradha Sharma "To Assess the Severity and Mortality among Covid-19 Patients after Having Vaccinated: A Retrospective Study" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-5 , August 2021, URL: https://www.ijtsrd.com/papers/ijtsrd45065.pdf Paper URL: https://www.ijtsrd.com/other-scientific-research-area/other/45065/to-assess-the-severity-and-mortality-among-covid19-patients-after-having-vaccinated-a-retrospective-study/prof-dr-binod-kumar-singh
Archisman Nandy
The objective of this study is to make a comparison between five (5) most affected countries (USA, Brazil, U.K., Italy and India) of the world by Covid-19. The study is based on the secondary data. For conducting this study published data in online portal www.worldometers.info has been used. 4 months i.e. August 2020 to November 2020 has been chosen to carry out this study. For data analysis and interpretation Microsoft excel software (version 2019) has been used. Basic arithmetic technique and ratio analysis has been used in this study for data interpretation purpose. For measuring cyclical fluctuations in Covid-19 cases and its corresponding death cases, visual representation has been incorporated as bar diagram. Relevant images have been sourced from authentic sources and used in this study for satisfying the research objective. Finally the study has revealed that during the period of August 2020 to November 2020 Brazil is the most affected country and United States of America is the least affected country based on the mortality rate among the five countries taken as sample for this study
Evaluation of Signs and Symptoms Post Recovery in COVID Patients: A Questionn...DrHeena tiwari
This document describes a questionnaire survey of 287 individuals who recovered from COVID-19. The survey found that only 10.8% reported no ongoing symptoms, while most reported fatigue (72.8%), anxiety (38%), joint pain (31.4%), or other symptoms. Symptom severity was related to severity of initial COVID-19 infection and presence of pre-existing conditions. The study aims to evaluate ongoing signs and symptoms in post-recovery COVID patients.
This document discusses long-term or post-COVID conditions that can occur in people who have had COVID-19. It defines post-COVID conditions as new, returning, or ongoing health problems that can last 4 or more weeks after initial infection. Common symptoms include fatigue, shortness of breath, brain fog, and joint pain. Post-COVID conditions can result from direct organ damage from severe COVID-19, as well as indirect effects like those from extended hospitalization. Both children and adults can experience post-COVID conditions. The best prevention is vaccination against COVID-19.
This document reviews the neurological sequelae of COVID-19. It finds that COVID-19 can cause olfactory and respiratory dysfunction with average recovery within 1 month, though some patients experience symptoms up to 8 months later. Headaches are also very common in patients with persistent COVID-19 symptoms. The document concludes that while many studies have focused on acute COVID-19 symptoms, more longitudinal studies are needed to fully assess neurological sequelae.
Affects of SARS Cov 2 on Different Parts HHW.pptxRakeshKhetrapal1
The document discusses how SARS CoV 2 affects different parts of the human body. It outlines that the virus can cause lung complications like pneumonia and ARDS. It also affects the kidneys by potentially causing harm and loss of function. The brain is affected as well, with patients experiencing issues ranging from loss of smell and taste to life-threatening strokes. The liver can also be impacted, with people with preexisting liver conditions at higher risk of severe illness. While the evidence of ocular transmission is still being studied, the eyes' mucus membranes make them susceptible to infection if droplets enter the eye.
Affects of SARS Cov 2 on Different Parts HHW.pptxRakeshKhetrapal1
The document discusses how SARS CoV 2 affects different parts of the human body. It outlines that the virus can cause lung complications like pneumonia and ARDS. It also affects the kidneys by potentially causing harm and loss of function. The brain is affected as well, with patients experiencing issues ranging from loss of smell and taste to life-threatening strokes. The liver can also be impacted, with people with preexisting liver conditions at higher risk of severe illness. While the evidence of ocular transmission is still being studied, the eyes' mucus membranes make them susceptible to infection if droplets enter the eye.
Long COVID_ Only THESE 7 Symptoms Are The Direct Result.pdfmyhealthfitclub
Long COVID - myhealthfitclub
Long COVID: Only THESE 7 Symptoms Are The Direct Result
02/02/2023 by Yogesh
Long COVID : Post-COVID Condition
Long Covid : If you have recovered from COVID-19 but are still experiencing certain symptoms you could have post Corona Virus condition or “long Corona virus”. What are these symptoms? How long do they last and are there any treatment options?
Also Read : Most Effective Abs Exercises To Burn Belly Fat
01/9 Symptoms Of Long COVID To Look For
01/9 Symptoms of long COVID to look for
Long COVID or post-corona virus condition has been associated with a long list of symptoms. However, a new study has found that there are only 7 long-term health symptoms that are directly associated with long corona virus. These symptoms can interfere with your day-to-day functioning and you may not be able to function exactly like before your initial COVID_infection. The findings can help researchers better understand how SARS-CoV-2 may mutate.
Also Read : Know What Is Parkinson’s Disease And Symptoms ?
02/9 About the study
The researchers at the University of Missouri analyzed 52,461 patients’ electronic medical records in the United States. All of the patients had been diagnosed with a Corona virus infection before April 14, 2022.Researchers studied the top 47 most commonly reported health symptoms from long-COVID. They found only seven of the symptoms applied to a subgroup of infected adult patients. Following are the 7 symptoms, which can last up to a year.
03/9 Fast-beating heart
This symptom includes feeling your heart beat rapidly or irregularly in your chest. You may also feel lightheaded or dizzy, especially upon standing.
Read more: Know What Is Pneumonia How To Identify ?
04/9 Long COVID – Hair loss
04/9 Long COVID - Hair loss
People can experience hair fall long after COVID, due to a condition called Telogen Effluvium. This can happen when your body is subjected to physical and emotional stress, such as while fighting a COVID_infection. The stress from COVID_shocks your body and disrupts the growth-rest cycle. This results in an increased shedding of hair.
05/9 Long COVID – Fatigue
05/9 Long COVID - Fatigue
This is one of the most common long COVID symptoms. Researchers in Iran undertook a meta-analysis covering 52 studies with 127,117 participants. They found that 42.5% of people who develop long_COVID have chronic fatigue that can persist for months, despite medical care.
Read more: Do BB.1.5 Variant Of Omicron Infect People : WHO?
06/9 Long COVID – Chest pain
06/9 Long COVID - Chest pain
Chest pain or chest discomfort is also a common symptom of long COVID. This type of pain can feel like the muscles in your chest are sore. It can hurt when you touch it and the pain gets worse from movements such as turning around or stretching.
07/9 Shortness of breath
Long after your initial COVID infection, you may find yourself catching your breath and feel short of breath more easily. This can happen even if you d
COVID-19 AND UROLOGY: A Comprehensive Review of the LiteratureValentina Corona
This article reviews the impact of the COVID-19 pandemic on the practice of urology. It discusses how the pandemic has led to the postponement of non-urgent surgeries and changes in residency training. It also examines the potential effects of COVID-19 on the urinary tract, noting that the kidneys and bladder may be at risk of viral invasion due to the presence of ACE2 receptors. The article reviews recommendations regarding kidney transplantation during the pandemic and reports limited cases of COVID-19 infection in renal transplant recipients.
The document discusses coronavirus disease (COVID-19) including its definition, transmission, clinical presentation, course, and diagnostic testing recommendations. It defines healthcare personnel and notes COVID-19 is a new coronavirus strain discovered in 2019 that is zoonotic, mainly spread through respiratory droplets. Symptoms can range from mild to severe and include fever, cough and shortness of breath. Older patients and those with chronic conditions are at higher risk. Diagnostic testing is recommended for suspected cases using molecular tests on respiratory specimens.
COVID-19: советы ВОЗ по использованию масокPravotv
This document provides updated guidance from the WHO on the use of medical and non-medical masks in the context of the COVID-19 pandemic. It summarizes evidence that COVID-19 spreads via respiratory droplets and contact with infected surfaces. The guidance recommends medical masks for health workers providing direct care to COVID-19 patients without aerosol-generating procedures, and respirators for those performing such procedures. It also recommends targeted continuous use of medical masks by health workers in areas with community COVID-19 transmission.
The document provides information on COVID-19 and ways to protect against it. It discusses what coronaviruses are, details of the SARS-CoV-2 virus, how the disease spreads via respiratory droplets, those most at risk like the elderly and those with pre-existing conditions, common symptoms like fever and cough, and the importance of practices like hand washing, social distancing, and masks to prevent transmission. It aims to fight misinformation by providing an authentic resource on understanding the pandemic and staying safe.
This document provides an overview of COVID-19, including its epidemiology, risk factors, pathophysiology, symptoms, transmission, diagnosis, treatment, prevention, and nursing interventions. It notes that over 3.3 million new cases were reported globally in the past week, with nearly 46 million total cases and 1.2 million deaths. Common symptoms include fever, cough, and fatigue, while severe symptoms can include trouble breathing, organ failure, and death. The main modes of transmission are respiratory droplets and contact with contaminated surfaces. Treatment focuses on managing symptoms, as there is no vaccine or antiviral specifically for COVID-19. Prevention emphasizes hand hygiene, physical distancing, and use of face coverings.
Guillain Barre Syndrome & Covid-19: A Case Reportclinicsoncology
Besides respiratory symptoms, coronavirus disease 2019 (COVID-19), like the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), has neurological signs. Symptoms like myalgia, headaches, dizziness, anosmia, ageusia and disorder of consciousness confirms that the nervous system is involved in COVID-19 infection.
Guillain Barre Syndrome & Covid-19: A Case Reportpateldrona
Besides respiratory symptoms, coronavirus disease 2019 (COVID-19), like the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), has neurological signs
Guillain Barre Syndrome & Covid-19: A Case Reportkomalicarol
Besides respiratory symptoms, coronavirus disease 2019
(COVID-19), like the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), has neurological signs. Symptoms like myalgia,
headaches, dizziness, anosmia, ageusia and disorder of consciousness confirms that the nervous system is involved in COVID-19 infection. Guillain barre syndrome (GBS) is a neurological disorder
that usually follows a viral infection, it is possible that COVID-19
infection and GBS are closely related. In this case report, we try to
elucidate the relation between SARS-CoV-2 and GBS.
Similar to Examination of the effects of long-term COVID-19 impacts on patients with neurological disabilities using a neuromachine learning model (20)
A case report of posterior reversible encephalopathy syndrome in a patient di...bijnnjournal
Posterior reversible encephalopathy syndrome (PRES), a clinical radiological syndrome, is characterized by the
abrupt development of neurological symptoms such as headaches, convulsions, altered sensorium, and visual
problems. PRES has been linked to a number of risk factors or etiologies, including the use of immunosuppressants
or cytotoxins, hypertensive encephalopathy, eclampsia, preeclampsia, and underlying autoimmune diseases.
A 41-year-old female was admitted with acute necrotizing emphysematous pancreatitis complicated by posterior
reversible encephalopathy syndrome
Balint syndrome: an unusual triad, Balint syndrome: an unusual triadbijnnjournal
The paper investigates a case of sudden loss of vision in a patient with recent history of blurred vision of right eye
diagnosed with Central retinal artery occlusion (CRAO). The point of interest of this case report is that the clinical
features are something different from those of a CRAO and revealed cardinal triad of simultanagnosia, optic ataxia,
and oculomotor apraxia which are conclusive of a rare clinical entity known as Balint syndrome.
Clinical insights and challenges: A rare case report of Leigh syndromebijnnjournal
Leigh syndrome is a severe neurological disorder that impairs mobility and respiration, among other bodily
functions. Progressive brain deterioration is what makes it distinctive. This case report describes a 10-monthold female child who displayed symptoms such as vibratory movements in the right upper and left lower limbs,
failure to thrive, decreased activity, and vomiting after consuming supplemental feeds. Multiple clinical signs of
Leigh syndrome, including missed developmental milestones and mild acute malnutrition, were identified during
a physical examination. So the symptoms that led to the diagnosis of Leigh syndrome were quadriparesis,
dystonia, intermittent stridor (laryngeal dystonia), and bulbar weakness
Endovascular complications: Antiplatelet management for flow diversionbijnnjournal
Up to 3−5% of the general population is affected by cerebral aneurysms that are associated with both modifiable
as well as non-modifiable risk factors ranging from familial to acquired neurovascular conditions. The initial
treatment option was aneurysm clipping and evolved to including primary or adjuvant endovascular treatment.
Aneurysm re-rupture, although rare, can have devastating consequences such as intracranial bleeding and carotidcavernous fistula. Emergent surgery in view of delayed aneurysm rupture in patients maintained on dual antiplatelet
therapy presents with the need to carefully assess the procedure-related risk factors and evaluate the patients’
platelet function. With the advent of novel technology, flow diverters came into play
Whole-Body vibration therapy: an overviewbijnnjournal
Concern has been raised about whole-body vibration training (WBVT), which activates skeletal muscles by
employing vibrations rather than a mass load or dynamic exercise. As vibration massage and local vibration applied
to muscles show promising benefits, vibration treatment and exercise became widely used in rehab. Studies are
still being conducted to fully comprehend the cumulative impacts and long-term safety of this training program.
This study gives an outline of WBVT, explaining its physiology and advantages as well as some safety aspects,
contraindications, and instructions for applying it in a clinical environment.
Spinal tumor embolization: benefit for surgical resectionbijnnjournal
The embolization of hypervascular spinal tumors preoperatively has shown to be a worthwhile adjunctive procedure to minimize the elevated risks associated with surgical resection, such as intraoperative blood loss and its
associated complications. Resection of these hypervascular tumors is necessary for local tumor control, reduction
in patient-reported pain, improved neurological functioning, and spinal stability. This adjunctive procedure has
been associated with improved surgical outcomes and easier facilitation of surgical resection. As such, we provide a review of the current literature examining the employment of this technique
Intracranial venous sinus thrombosis: Medical and surgical management conside...bijnnjournal
Cerebral venous thrombosis is a serious neurological condition characterized by thrombus formation in the venous
sinuses or cerebral veins. Although rare, it is a potentially fatal condition that requires prompt diagnosis and
treatment. This review aims to present the most current trends in our understanding of CVT risk factors, diagnosis,
medical management, role of endovascular management, risk of intracranial hemorrhage, and emerging therapies.
Most cases of CVT are diagnosed by clinical features and neuroimaging suggestive of sinus occlusion. While
anticoagulation with heparin is the mainstay of medical management, direct-oral anticoagulants are emerging as
a potential alternative, and severe cases have been managed successfully with thrombectomy and/or intrasinus urokinase thrombolysis. Despite recent advances in anticoagulation therapy and diagnostics, larger randomized studies are required to adequately assess these emerging therapies and better inform the management of patients suffering from CVT.
Recurrent meningioma: When to intervene, Recurrent meningioma: When to intervenebijnnjournal
Meningioma occurs most frequently as a benign tumor central nervous system that is common in old females.
Radiation exposure and deletion of the NF2 gene are known risk factors. However, there is no consensus about
the role of sex hormones. Meningiomas are usually benign tumors, but 6% can be anaplastic or atypical. Most
asymptomatic patients do not require treatment, but complete surgical resection is recommended for symptomatic
patients. If a tumor returns after being resected previously, it is recommended to be resected, followed by
radiotherapy in some cases. Meningiomas (benign, atypical, and malignant) recurring after standard treatment
fails could be treated with hormone therapy, chemotherapy, target therapy, and calcium channel blockers
Diabetes mellitus management in the context of cranial tumorsbijnnjournal
The study of the relationship between cancer and diabetes mellitus (DM) has been under investigation for many
decades. Particularly in the field of neurology and neurosurgery, increasing emphasis has been put on the
examination of comorbid DM in patients with cranial tumors. Namely, as the most common and invasive type
of malignant adult brain tumor, glioblastoma (GBS) has been the focus of said research
The development of transcranial magnetic stimulationbijnnjournal
This review describes the development of transcranial magnetic stimulation in 1985 and the research related to
this technique over the following 10 years. It not only focuses on work done at the National Institutes of Health
but provides a survey of other related research as well. Key topics are the calculation of the electric field produced
during magnetic stimulation, the interaction of this electric field with a long nerve axon, coil design, the time course
of the magnetic stimulation pulse, and the safety of magnetic stimulation.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
low birth weight presentation. Low birth weight (LBW) infant is defined as the one whose birth weight is less than 2500g irrespective of their gestational age. Premature birth and low birth weight(LBW) is still a serious problem in newborn. Causing high morbidity and mortality rate worldwide. The nursing care provide to low birth weight babies is crucial in promoting their overall health and development. Through careful assessment, diagnosis,, planning, and evaluation plays a vital role in ensuring these vulnerable infants receive the specialize care they need. In India every third of the infant weight less than 2500g.
Birth period, socioeconomical status, nutritional and intrauterine environment are the factors influencing low birth weight
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfRahul Sen
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...AyushGadhvi1
learning occurs when a stimulus (unconditioned stimulus) eliciting a response (unconditioned response) • is paired with another stimulus (conditioned stimulus)
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
Examination of the effects of long-term COVID-19 impacts on patients with neurological disabilities using a neuromachine learning model
1. BOHR International Journal of Neurology and Neuroscience
2023, Vol. 1, No. 1, pp. 22–29
DOI: 10.54646/bijnn.2023.03
www.bohrpub.com
Examination of the effects of long-term COVID-19 impacts on
patients with neurological disabilities using a neuromachine
learning model
A. Vaniprabha1, J. Logeshwaran2*, T. Kiruthiga3 and Krishna Bikram Shah4
1Department of Electronics and Communication Engineering, SNS College of Engineering, Coimbatore, India
2Department of Electronics and Communication Engineering, Sri Eshwar College of Engineering, Coimbatore, India
3Department of Electronics and Communication Engineering, Vetri Vinayaha College of Engineering and Technology,
Tholurpatti, India
4Department of Computer Science and Engineering, Nepal Engineering College, Bhaktapur, Nepal
*Correspondence:
J. Logeshwaran,
eshwaranece91@gmail.com
Received: 03 March 2023; Accepted: 27 March 2023; Published: 14 April 2023
Currently, studies have shown that one in three people infected with coronavirus disease-19 (COVID-19) is likely
to have had long-term exposure to COVID-19, known as long-term COVID-19. Clinical studies indicate that many
people infected with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) COVID-19 pandemic have
long-term COVID-19 exposure. According to the study, it has been said that people with diabetes and obesity, and
people who have received organ transplants, are more likely to suffer from this long-term effect of COVID-19. In
this article, the effects of long-term COVID-19 exposure on neurological disability patients are analyzed with the
help of a neuromachine learning model. The proposed model also shows that this long-term COVID problem does
not depend on the factors such as race, age, gender, and socioeconomic status of those people. According to the
proposed model, people suffering from long-term COVID problems continue to suffer from physical fatigue and
shortness of breath and are regularly monitored and classified as per the proposed instructions. Even after they
recover from the disease, various side effects are seen.
Keywords: COVID-19, long-term COVID-19, SARS-CoV-2, diabetes, obesity, organ transplants, neurological
disability, neuromachine learning
Introduction
The has been affecting us for some time now. The virus
is an acute illness that usually lasts more than three weeks
(1). However, some patients with neurological disabilities
experience various lingering symptoms even months after the
infection (2). According to the World Health Organization
(WHO), it has been mentioned that some long-term health
disorders may occur in people who have been exposed to
the coronavirus for a long time (3, 4). This means that these
effects can occur if there is a corona infection for more than
12 weeks (5) and it can affect many organs. It can also develop
a variety of long-term symptoms.
Researchers are investigating what causes this strange
vulnerability, and now a new study reports on people who
have been infected during the corona virus pandemic (6, 7).
Along with people experiencing hair loss, headaches, and
sore throats during this corona infection, some other side
effects also occur (8). And the findings suggest that people
who are obese are more likely to have prolonged COVID-19
symptoms (9).
The new research comes from a two-week study of corona
virus neurological disability patients between March 2020
and March 2021. The study is published in the Journal of
Scientific Reports. The final sample of the study consisted
of 308 infected, non-hospitalized individuals. However, 23%
22
2. 10.54646/bijnn.2023.03 23
of these patients with neurological disabilities reported new-
onset symptoms more than 12 weeks after infection.
This can be considered a long-term effect of corona
infection (10–12). It is known that some of the health effects
persist for these people who have had long-term COVID-19.
According to the study, the researchers found that
headaches (22%), colds or stuffy noses (19%), stomach
problems (18%), and fatigue (17%) continued to be the most
common symptoms. And the primary long-term symptoms
in children are fatigue, headaches, difficulty with schoolwork,
mood disorders, and shortness of breath (13–15).
Similarly, those with Omicron disease, which is now
dominant in most countries, also have long-term infectious
effects (16). Researchers warn that many health disorders are
likely to persist in people infected with the Omicron type of
corona even longer than the previous corona infection (17).
Physical and mental rest are essential for people with
long COVID-19. Everyone needs different amounts of rest
(18). Therefore, proper rest for the body and mind is
required until the symptoms subside (19). If proper rest is
not taken between daily activities, long-term COVID-19 will
additionally worsen or persist (20).
Avoid or reduce cell phone and television use to get
a good night’s rest. Avoid spending time on social media
(21). Meditate if possible. Don’t neglect the rest. Although
systematic exercise and physical activity (walking, running,
swimming, and bicycling) have physical and mental benefits,
guidelines for people with long-term COVID-19 have not yet
been developed (22, 23).
In cases of fatigue, low blood oxygen levels, fatigue, etc.
anyone with chronic COVID-19 should not do chiropractic
activities/exercises on their own without proper medical
advice/monitoring/recommendation (24). Neurological
disability patients who had previously suffered from the
COVID-19 infection believed that once they recovered from
it, they would get rid of all the symptoms they experienced.
However, over time, long-term COVID-19 has become a
common problem among those who have recovered from
the coronavirus (25, 26).
These lingering symptoms not only take a toll on people’s
physical health. One in five survivors of the corona virus was
reported to have symptoms after 5 weeks and at 12 weeks (27,
28). Additionally, a team of British researchers studying long-
term symptoms in COVID-19 neurological disability patients
found that long-term COVID-19 affects women twice as
often as men (29).
Related works
Most people recover within a few weeks of contracting the
virus. However, some people may have symptoms for 4 to
12 weeks or even longer. They are called “Long COVID-
19.” In this case, the question has arisen for many people
whether the Omicron infection with mild symptoms will
have long-term effects (1).
Experts commented that it is too early to decide whether
Omicron can cause long-term COVID-19. But they suggest
that long-term effects from omicron variation are possible.
According to the WHO, long-term COVID-19 is diagnosed
several days after the infection is confirmed. It said long-term
COVID-19 effects can be seen for at least 90 days after the
initial symptoms clear up (4).
According to the study, more than one-third of people
who have recovered from the common corona infection
suffer from chronic COVID-19. They will have problems like
fatigue, brain damage, breathing disorders, and anxiety (7).
Those who are admitted to the hospital after the infection
worsens are more likely to develop long-term COVID-19.
At the same time, studies suggest that people with mild
symptoms may develop chronic COVID-19. Omicron began
rolling out globally at the end of last year. This strain caused
less damage than Delta.
However, hospitals were overwhelmed by the rapid spread
(8). Meanwhile, scientists are actively working to find out
why the long-standing COVID-19 problem is occurring. It
is thought to be an autoimmune disorder (12). It is thought
that small microclots can cause disabling symptoms or
reactivate latent viruses in the body. In two laboratory results,
vaccination before exposure to the corona virus reduced the
likelihood of contracting long-term COVID-19. At least it
keeps the disease from getting worse (18).
Long-term, COVID-19 has become a growing concern
among people. Although it is already known that severe
COVID-19 neurological disability patients have symptoms
of a long-term COVID-19 problem, studies show that
50% of COVID-19 neurological disability patients who
experience mild-to-moderate symptoms experience clinical
complications 6 months after infection (30).
Long-term COVID-19 is the condition of experiencing
the problems caused by the COVID-19 infection for a long
period of time. This means that people infected with COVID-
19 may experience some permanent damage to areas such
as the lungs, heart, kidneys, or brain, or may continue to
experience lasting symptoms despite no damage to these
organs (31).
Proposed model
Since COVID-19 is a respiratory disease, it is likely to cause
long-term damage to the lungs. SARS-CoV-2 has the ability
to cause inflammatory changes in the lungs. It negatively
affects lung tissue and air sacs, leading to long-term effects.
While it is important to understand the length of time it takes
for COVID-19 to develop into a long COVID-19, it is also
important to recognize the early signs of a long COVID-19.
Most people recover within a few weeks of being infected
with the corona virus.
3. 24 Vaniprabha et al.
FIGURE 1 | Long-term COVID-19 symptoms’ dataset.
But in some people, symptoms may persist for 4 to
12 weeks or even longer. These prolonged COVID-19 related
symptoms are called “long COVID-19.” Long-term COVID-
19 infection, according to current medical research, can affect
anyone who has been infected with COVID-19. In particular,
people with mild-to-moderate symptoms have been shown
to be more susceptible to long-term disease. The symptoms’
dataset was shown in Figure 1.
• Fatigue: Suffers from excessive fatigue. This fatigue,
unlike normal fatigue, can be very severe. It is not
reduced by sleeping and resting. This fatigue can
be unpredictable, both when it comes on and when
it gets worse. Even doing normal daily tasks may
become difficult.
• Aggravation of symptoms: Severe fatigue can affect
thinking ability, exercise tolerance, etc., if you do
strenuous physical work, emotional stress, or high-
stepping work. It can also cause physical pain. This is
known as fatigue after strenuous physical or mental
work. Treating it is a major challenge.
• Dizziness: The autonomic nervous system is the part of
our body that controls automatic functions like blood
pressure, digestion, breathing, body temperature, etc.
When this zone is not functioning properly, there
can be problems controlling body temperature, blood
pressure, etc. When such difficulties occur, symptoms
such as dizziness, difficulty breathing, and stuttering
may appear. These symptoms can be triggered by viral
infections like COVID-19. When sitting or standing
up due to COVID-19, the heart rate may increase and
dizziness or lightheadedness may occur.
• Brain damage: Clinical studies are confirming that
many people with long-term COVID-19 develop
brain damage. This is called “brain fog.” Problems
with concentration at work, memory, thinking, and
controlling emotions seem to occur.
• Respiratory disorders: Changes in breathing patterns
that occurred early in the course of the COVID-
19 infection may not reverse in some people and
persist into the long COVID-19 period. Such disorders
differ from the normal breathing pattern and indicate
excessive breathing. This problem can be caused by
things like breathing through the mouth or upper chest
and using the wrong breathing muscles.
While recovering from a COVID-19 infection, body
fatigue is common. You may feel so weak that you can’t even
do normal daily tasks (sitting, bathing, reading a book, etc.).
Three strategies are recommended to deal with this problem:
moderation, planning, and prioritization. This was shown in
Figure 2.
• Moderation: Do not do too much work at once, to the
point of exhaustion. Work can be broken down into
smaller parts, or you can continue after resting for a
few minutes in between.
• Planning: Divide the daily/weekly tasks according to
physical strength and plan in advance which tasks can
be done on which days.
• Prioritization: List and categorize tasks according to
which work needs to be done immediately or must
be done, which can be done later, and who can help
get a job done. Complete tasks according to their
importance.
These three strategies should be followed even when going
about daily work, from home to office. Medical experts
recommend not going back to full-time work at once
but gradually increasing the hours or dividing the work
according to your body.
As soon as the novel corona virus began to spread strongly,
many symptoms appeared among the population. While the
list of corona virus symptoms continues to grow, there are
some symptoms that are more common and prevalent among
those infected. Common symptoms of COVID-19 include
the following:
• Fever
• Runny nose and stuffy nose
• Fatigue
• Gastrointestinal infection
• Loss of smell and taste
Experts say that those recovering from the corona virus
should be prepared to face the physical side effects of the
illness in the months that follow, while also following disease
prevention and healthy lifestyle measures after recovery.
After recovery, it is said that some disease-related and
new symptoms are revealed after a few months. Symptoms
include shortness of breath, fatigue, muscle spasms, cough,
irregular heartbeat, depression, and kidney problems.
The study revealed that about one and a half months after
recovery from the disease, excessive hair loss, inflammation
4. 10.54646/bijnn.2023.03 25
FIGURE 2 | Proposed strategies to resolve the problem.
of the heart, chest pain, diarrhea, excessive forgetfulness, an
inability to recognize taste, and suffering from not being able
to smell had occurred to some of the people. Doctors refer to
those who suffer from chronic effects after recovering from
Corona as long-term sufferers (long haulers). This type of
infection is known as long COVID-19.
The effects that occur even after recovery are similar to
those previously experienced by those infected with SARS,
swine flu, and Ebola. It is said that even though the long-term
effects of this corona will not be life-threatening, it will be
very challenging for them to lead a healthy life.
To avoid danger, people recovering from Corona are
being advised not to ignore any symptoms in the coming
years. They are also advised to lead as healthy a lifestyle
as possible. A healthy lifestyle means living a healthy
lifestyle, like eating nutritious food and being free from
alcohol and smoking.
Researchers, who say that stress is the most important
effect of this epidemic, both during the illness and after it
subsides, predict that those who have been affected by the
corona virus for a long time may have more mental health
problems. So they are advised to take extra care of their
mental health.
It has been recommended that the government take steps
to improve the mental health of its people, as well as the
efforts it makes to improve their physical health. Some recent
studies suggest that children are more vulnerable to long-
term exposure to the virus.
In a British study last year, the health of 500 children
who were treated for the corona virus was monitored. At
least 25% of the children who returned home from treatment
were recently re-examined and found to be suffering from
long-term exposure to the virus.
It has been found that these children have more problems
like fatigue, sleep-related problems, and a lack of emotion. As
this is a new form of the corona virus, medical experts are still
researching a longer COVID-19 treatment. They have some
recommendations for people experiencing this, as shown in
Figure 3.
FIGURE 3 | Proposed recommendations.
• First, adequate sleep and rest are recommended.
• As long-term symptoms of COVID-19 can also affect
brain function, it’s important to lift your mood and take
care of your mental health.
• For that, you need to be calm and active. Maintain a
daily routine to keep your motivation high and develop
a sense of consistency.
• Relieve yourself from muscle and joint pain and do
exercises that strengthen your body.
• Consume adequate fluids and healthy food.
It is worth recalling that last February, the WHO had
warned about this type of damage. If we want to say it in the
words that they mentioned, “One in ten people is suffering
from the corona virus for a long time, and such effects start
12 weeks after corona virus infection.” Therefore, we should
pay attention and give importance to the health of Corona
neurological disability patients, not only during the infection
period but also during the recovery from the disease.
Results and discussion
The proposed neuro machine learning model (NMLM) was
compared with the existing COVID-19 detection systems
using deep-learning algorithms (CDS-DLA), COVID-19
diagnosis using deep learning algorithms (CD-DLA),
ensemble learning algorithms (ELA), and the triangular
patient monitoring system (TPMS).
Computation of persistent cough
symptoms
Coronavirus disease-19 (COVID-19) can cause irritation and
inflammation in the respiratory tract, causing a persistent
cough. And a cough induced by a COVID-19 infection can
last for a week or a month. Often this persistent cough
5. 26 Vaniprabha et al.
TABLE 1 | Comparison of persistent cough symptoms.
No. of inputs CDS-DLA CD-DLA ELA TPMS NMLM
100 80.76 74.82 67.71 88.82 96.18
200 80.43 73.32 67.12 86.95 95.17
300 79.09 72.21 66.14 86.12 95.01
400 77.95 71.83 64.93 85.21 94.05
500 76.90 70.82 63.79 84.29 94.48
600 76.19 69.89 62.68 82.96 93.28
700 74.89 68.89 61.98 82.09 93.13
FIGURE 4 | Comparison of persistent cough symptoms.
is accompanied by chronic fatigue, cognitive impairment,
dyspnea, or pain. The computation of persistent cough
symptoms is shown in Table 1.
Figure 4 demonstrates the comparison of persistent cough
symptoms. The corona virus infection has been spreading for
over a year now. Researchers are conducting various studies
to better understand this virus and come up with ways to treat
it. As days go by, this virus changes its shape and becomes
life-threatening.
From the comparison in Table 1, the proposed
neuromachine learning model obtained 94.05% of
the management of persistent cough symptoms in a
saturation test. In the same range, the existing CDS-DLA
reached 77.95%, CD-DLA obtained 71.83%, ELA obtained
64.93%, and TPMS achieved 85.21% of persistent cough
symptom management.
Computation of diarrhea symptoms
According to studies, digestive health can also suffer due to
COVID-19. Diarrhea is said to be a common symptom of
COVID-19 infection and an early symptom of long-term
TABLE 2 | Comparison of diarrhea symptoms.
No. of inputs CDS-DLA CD-DLA ELA TPMS NMLM
100 83.06 77.12 64.31 86.08 97.09
200 82.73 75.62 63.72 84.21 96.05
300 81.39 74.51 62.74 83.38 95.92
400 80.25 74.13 61.53 82.47 94.96
500 79.20 73.12 60.39 81.55 95.39
600 78.49 72.19 59.28 80.22 94.15
700 77.19 71.19 58.58 79.35 94.04
FIGURE 5 | Comparison of diarrhea symptoms.
COVID-19. COVID-19 symptoms include a sore throat and a
runny nose. The computation of diarrhea symptoms is shown
in Table 2.
Figure 5 shows the comparison of diarrheal symptoms.
Both of these can lead to a hoarse voice. If he/she
experienced this type of symptom during the infection
period, he/she may experience it again after he/she recovers
from the corona virus.
From the comparison in Table 2, the proposed
neuromachine learning model obtained 94.96% of diarrhea
symptoms management in a saturation test. In the same
range, the existing CDS-DLA reached 80.25%, CD-DLA
obtained 74.13%, ELA obtained 61.53%, and TPMS achieved
82.47% of diarrhea symptom management.
Computation of loss of appetite
symptoms
People who have recovered from COVID-19 have reportedly
experienced symptoms such as loss of appetite and taste
loss after fully recovering from the disease. In most people,
the symptoms of COVID-19 last about 2–3 weeks. The
6. 10.54646/bijnn.2023.03 27
TABLE 3 | Comparison of loss of appetite symptoms.
No. of inputs CDS-DLA CD-DLA ELA TPMS NMLM
100 81.80 84.86 71.87 94.52 96.35
200 80.17 83.12 70.29 93.10 95.06
300 79.69 80.78 68.09 91.84 94.05
400 78.40 79.97 66.46 89.85 93.16
500 76.29 77.68 65.32 87.38 92.79
600 74.80 75.75 63.12 85.94 91.15
700 72.99 74.02 61.97 84.22 90.78
FIGURE 6 | Comparison of loss of appetite symptoms.
computation of loss of appetite symptoms is shown in
Table 3.
Figure 6 shows the comparison of loss of appetite
symptoms. There is one more category of neurologically
disabled patients. These patients constitute 10% of the
total number of affected neurological disability patients,
and they continue to experience symptoms for more than
a month. They are called the “long-distance travelers” of
the corona virus.
According to the comparison in Table 3, the proposed
neuromachine learning model managed 93.16% of the loss
of appetite symptoms in a saturation test. In the same range,
the existing CDS-DLA reached 78.40%, CD-DLA obtained
79.97%, ELA obtained 66.46%, and TPMS achieved 89.85%
of loss of appetite symptoms management.
Computation of wheezing symptoms
Although COVID-19 is a respiratory disease, it can cause
severe breathing difficulties in patients with neurological
disability. If a person suffers from such severe symptoms of
TABLE 4 | Comparison of wheezing symptoms.
No. of inputs CDS-DLA CD-DLA ELA TPMS NMLM
100 91.69 80.76 71.71 93.51 96.35
200 90.20 78.79 69.29 91.31 96.36
300 89.40 77.66 68.88 90.51 95.16
400 87.07 76.47 67.28 89.84 94.68
500 86.06 76.08 64.96 88.41 93.25
600 85.42 74.56 63.71 87.32 92.09
700 84.76 74.32 60.98 86.84 91.32
FIGURE 7 | Comparison of wheezing symptoms.
corona, he/she may face long-term complications. Long-term
symptoms of COVID-19 last for at least a month.
Research is being conducted on this particular type of viral
infection, and so far, not much detail has been discovered.
The computation of wheezing symptoms is shown in
Table 4.
Figure 7 shows the comparison of wheezing symptoms.
Sometimes you may recover and test negative, but symptoms
may last for 2 to 3 months. According to experts, there are
two possible causes of prolonged COVID-19 illness.
From the comparison in Table 3, the proposed
neuromachine learning model obtained 94.68% of
wheezing symptom management in a saturation test.
In the same range, the existing CDS-DLA reached
87.07%, CD-DLA obtained 76.47%, ELA obtained
67.28%, and TPMS achieved 89.84% of wheezing
symptom management.
First, even after 2 weeks, the virus persists in a
small amount in the neurological disability patient’s body.
Pathogens may not completely leave the body even after a
patient with neurological disability tests negative. Second, the
immune system may be deficient even after the virus has
7. 28 Vaniprabha et al.
left the body. There are two types of neurological disability
patients in this group: those with mild symptoms and those
with severe symptoms.
Conclusion
Long COVID-19 is a new term introduced in the
story of the coronavirus pandemic. Research is still
ongoing, and you should take care of your body and
do everything you can to boost your immune system.
Always remember that your body is an asset and
needs to be taken care of. Don’t lose hope, and keep
working on your body.
Even if you are experiencing prolonged COVID-19
symptoms, there is no need to panic. Try to manage
symptoms with good sleep and proper rest. You can also do
yoga and exercise.
However, if you are still unable to cope with the
symptoms, make an appointment with a doctor and
follow his/her recommendations and advice. The promising
results of the vaccine for long-distance travelers against
the corona virus will be revealed very soon. Researchers
are monitoring symptoms before and after vaccinations
and collecting blood samples to study the immune
response to vaccines.
The condition can affect all types of people, including
the young, the elderly, those who have been hospitalized
once, those who have never been hospitalized before, those
who are dealing with chronic conditions, and those who are
otherwise healthy.
Data availability
The data used to support the findings of this study are
included in the article. Should further data or information
be required, these are available from the corresponding
author upon request.
References
1. Blazek R, Hrosova L, Collier J. Internet of medical things-based
clinical decision support systems, smart healthcare wearable devices,
and machine learning algorithms in covid-19 prevention, screening,
detection, diagnosis, and treatment. Am J Med Res. (2022) 9:65–80.
2. Nassif AB, Shahin I, Bader M, Hassan A, Werghi N. COVID-19
detection systems using deep-learning algorithms based on speech and
image data. Mathematics. (2022) 10:564.
3. Logeshwaran J, Adhikari N, Joshi SS, Saxena P, Sharma A. The deep DNA
machine learning model to classify the tumor genome of patients with
tumor sequencing. Int J Health Sci. (2022) 6:9364–75.
4. AbdElhamid AA, AbdElhalim E, Mohamed MA, Khalifa F. Multi-
classification of chest X-rays for COVID-19 diagnosis using deep
learning algorithms. Appl Sci. (2022) 12:2080.
5. Alkady W, ElBahnasy K, Leiva V, Gad W. Classifying COVID-19 based
on amino acids encoding with machine learning algorithms. Chem Intell
Lab Syst. (2022) 224:104535.
6. Logeshwaran J, Malik JA, Adhikari N, Joshi SS, Bishnoi P. IoT-TPMS: An
innovation development of triangular patient monitoring system using
medical internet of things. Int J Health Sci. (2022) 6:9070–84.
7. Hammadah NH, Das NR, Nayak M, Swarnkar T. A comparative
study of deep learning algorithms for identification of COVID-19
disease using chest X-ray images. Innovation in Electrical Power
Engineering, Communication, and Computing Technology. Springer:
Singapore (2022). p. 165–72.
8. Gong H, Wang M, Zhang H, Elahe MF, Jin M. An explainable AI
approach for the rapid diagnosis of COVID-19 using ensemble learning
algorithms. Front Public Health. (2022) 10:874455.
9. Moulaei K, Shanbehzadeh M, Mohammadi-Taghiabad Z, Kazemi-
Arpanahi H. Comparing machine learning algo rithms for predicting
COVID-19 mortality. BMC Med Inform Decision Mak. (2022) 22:1–12.
10. Vijaya Baskar V, Sivakumar VG, Vimal SP, Vadivel M. Deep learning
analysis for COVID 19 using neural network algorithms. Recent
Advances in Internet of Things and Machine Learning. Cham: Springer
(2022). p. 103–10.
11. Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long- term
complications of COVID-19. Am J Physiol Cell Physiol. (2022) 322:C1–
11.
12. Ramesh G, Logeshwaran J, Aravindarajan V, Feny T. Eliminate the
interference in 5g ultra-wide band communi- cation antennas in cloud
computing networks. ICTACT J Microelectronics. (2022) 8:1338–44.
13. Han Q, Zheng B, Daines L, Sheikh A. Long-Term sequelae of COVID-
19: a systematic review and meta-analysis of one-year follow-up studies
on post-COVID symptoms. Pathogens. (2022) 11:269.
14. Sutharasan M, Logeshwaran J. Design intelligence data gathering and
incident response model for data security using honey pot system. Int J
Res Dev Technol. (2016) 5:310–4.
15. Gopi B, Logeshwaran J, Gowri J, Kiruthiga T. The moment probability
and impacts monitoring for electron cloud behavior of electronic
computers by using quantum deep learning model. NeuroQuantology.
(2022) 20:6088–100.
16. Gopi B, Logeshwaran J, Gowri J, Aravindarajan V. The Identification of
quantum effects in electronic devices based on charge transfer magnetic
field model. NeuroQuantology. (2022) 20:5999–6010.
17. Fernández-de-Las-Peñas C, Martín-Guerrero JD, Pellicer-Valero OJ,
Navarro-Pardo E, Gómez-Mayordomo V, Cuadrado ML, et al. Female
sex is a risk factor associated with long-term post-COVID related-
symptoms but not with COVID-19 symptoms: The LONG-COVID-
EXP-CM multicen- ter study. J Clin Med. (2022) 11:413.
18. Logeshwaran J, Rex MJ, Kiruthiga T, Rajan VA. FPSMM: Fuzzy
probabilistic based semi morkov model among the sensor nodes for
realtime applications. 2017 Inter- national Conference on Intelligent
Sustainable Systems (ICISS). IEEE (2017). p. 442–6.
19. Fuchs-Schündeln N, Krueger D, Ludwig A, Popova I. The long-term
distributional and welfare effects of Covid-19 school closures. Econ J.
(2022) 132:1647–83.
20. Bourmistrova NW, Solomon T, Braude P, Strawbridge R, Carter B. Long-
term effects of COVID-19 on mental health: a systematic review. J Affect
Disord. (2022) 299:118–25.
21. Raja S, Logeshwaran J, Venkatasubramanian S, Jayalakshmi M,
Rajeswari N, Olaiya NG, et al. OCHSA: designing energy-efficient
lifetime-aware leisure degree adaptive routing protocol with optimal
cluster head selection for 5G communication network disaster
management. Sci Prog. (2022) 2022:5424356.
22. Siripanthong B, Asatryan B, Hanff TC, Chatha SR, Khanji MY, Ricci
F, et al. The pathogenesis and long- term consequences of COVID-19
cardiac injury. Basic Transl Sci. (2022) 7(3_Part_1):294–308.
23. Ashraf BN, Goodell JW. COVID-19 social distancing measures and
economic growth: distinguishing short-and long-term effects. Finance
Res Lett. (2022) 47:102639.
8. 10.54646/bijnn.2023.03 29
24. Ramesh G, Logeshwaran J, Rajkumar K. The smart con- struction for
image preprocessing of mobile robotic systems using neuro fuzzy logical
system approach. NeuroQuantology. (2022) 20:6354–67.
25. Zarei M, Bose D, Nouri-Vaskeh M, Tajiknia V, Zand R, Ghasemi
M. Long-term side effects and lingering symptoms post COVID-19
recovery. Rev Med Virol. (2022) 32:e2289.
26. Logeshwaran J, Shanmugasundaram RN. Enhancements of resource
management for device to device (D2D) communication: a review.
2019 Third International Conference on I-SMAC (IoT in Social, Mobile,
Analytics and Cloud)(I-SMAC). IEEE (2019). p. 51–5.
27. Steenblock C, Hassanein M, Khan EG, Yaman M, Kamel M, Barbir
M, et al. Diabetes and COVID- 19: short-and long-term consequences.
Hormone Metab Res. (2022) 54:503–9.
28. Akhtar-Danesh N, Baumann A, Crea-Arsenio M, Antonipillai V.
COVID-19 excess mortality among long-term care residents in Ontario,
Canada. PLoS One. (2022) 17:e0262807.
29. Logeshwaran J. The topology configuration of protocol-based local
networks in high speed communication net- works. Multidisciplinary
Approach in Research. (Vol. 15), (2022). p. 78–83.
30. Tian T, Wu J, Chen T, Li J, Yan S, Zhou Y, et al. Long-
term follow-up of dynamic brain changes in patients recovered
from COVID-19 without neurological manifestations. JCI Insight.
(2022) 7.
31. Prem Anandh A, Ramesh G, Logeshwaran J, Kiruthiga T. Impact of
multiple disciplinary researches in maritime sector. Multidisciplinary
Approach in Research. (Vol. 13), (2022). p. 74–80.